// App-Quantinova.ai

: Epidemiology of lung function in a global severe asthma population

Researchers

Presenter

  • Michael Wechsler

Principal Investigators

  • Giorgio Canonica

  • Enrico Heffler

  • Rupert Jones

  • John Busby

  • Liam Heaney

  • Paul Pfeffer

  • David Jackson

  • Andrew Menzies-Gow

  • Richard Costello

  • Elaine Machale

  • Chin Kook Rhee

  • You Sook Cho

  • Neva Eleangovan

  • Lakmini Bulathsinhala

  • Isha Chaudhry

  • Ruth Murray

  • Chris Price

  • Victoria Carter

  • Marianna Alacqua

  • Trung Tran

  • James Zangrilli

  • David Price

Medical Centers

  • Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, United States,

  • Division of Allergy and Clinical Immunology, National Jewish Health, Denver, CO, United States,

  • Personalized Medicine Asthma & Allergy Clinic, Humanitas University & Research Hospital, Milan, Italy.

  • The Peninsula College of Medicine and Dentistry, Plymouth, United Kingdom

  • UK Severe Asthma and National Registry, Queen’s University Belfast, Belfast, United Kingdom

  • UK Severe Asthma Network and National Registry, Barts Health NHS Trust, London, United Kingdom,

  • UK Severe Asthma Network and National Registry, Guy's and St Thomas' NHS Trust and Division of Asthma, Allergy & Lung Biology, King's College London, London, United Kingdom,

  • UK Severe Asthma Network and National Registry, Royal Brompton & Hareï¬eld NHS Foundation Trust, London, United Kingdom,

  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Respiratory Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland

  • Royal College of Surgeons in Ireland, Clinical Research Centre, Smurfit Building Beaumont Hospital, Dublin, Ireland

  • Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of

  • Department of Allergy and Clinical Immunology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Korea, Republic of,

  • Optimum Patient Care, Cambridge, United Kingdom,

  • AstraZeneca, Gaithersberg, MD, United States,

Locations

  • United States

  • Italy

  • United Kingdom

  • Ireland

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • OPC Global and AstraZeneca

Result

  • N/A